Paper - WANFANG MED ONLINE

You Position: Home > Paper

Recent progress on mechanism of Acinetobacter baumannii resistance to β-lactam antibiotics

( views:256, downloads:245 )

Author:: No author available

Journal Title:: Chinese Journal of Clinical Infectious Diseases

Issue:: 4

DOI:: 10.3760/cma.j.issn.1674-2397.2012.04.016

Key Word:: 鲍氏不动杆菌;β-内酰胺类;抗药性;机制;Acinetobacter baumannii;β-lactams;Drug resistance;Mechanism

Abstract：鲍曼不动杆菌(Acinetobacter baumannii)是不动杆菌属(Acinetobacter spp.)的一个种类.其完整的分类学谱系为Cellular organisms;Bacteria;Proteobacteria;γ-proteobacteria;假单胞菌目;莫拉菌科;不动杆菌属,为严格需氧、无动力、过氧化氢酶阳性且氧化酶阴性[1].不动杆菌属的自然生态系统为水和土壤,在人类可定植于皮肤、伤口、呼吸道和消化道[2].农牧养殖业和临床医疗中抗菌药物滥用导致极度耐药菌的产生.

Reference

[1]张明新,朱敏,王玫,等.应用基质辅助激光解析电离飞行时间质谱鉴定常见细菌和酵母菌[J].2011,(11).
[2]王铁山,苏建荣.不同抗菌药物组合对多重耐药鲍曼不动杆菌的作用研究[J].2011,(10).
[3]Weinstein RA,Munoz-Price LS.Acinetobacter infection.[J].2008,358(12).
[4]Rodriguez RE,Ravasi P,Mussi MA,etc.ISAba825, a functional insertion sequence modulating genomic plasticity and bla(OXA-58) expression in Acinetobacter baumannii.[J].2011,55(2).
[5]P, Janssen,K, Maquelin,R, Coopman,etc.Discrimination of Acinetobacter genomic species by AFLP fingerprinting.[J].1997,47(4).
[6]Tian GB,Adams Haduch JM,Taracila M,etc.Extended-spectrum AmpC cephalosporinase in Acinetobacter baumannii: ADC-56 confers resistance to cefepime.[J].2011,55(10).
[7]Rodriguez Martinez JM,Nordmann P,Ronco E,etc.Extended-spectrum cephalosporinase in Acinetobacter baumannii.[J].2010,54(8).
[8]Jan, Walther-Rasmussen,Niels, H?iby.OXA-type carbapenemases.[J].2006,57(3).
[9]Bush K,Queenan AM.Carbapenemases: the versatile beta-lactamases.[J].2007,20(3).
[10]金茜,杨青,胡海棠,等.美罗培南联合舒巴坦对鲍曼不动杆菌体外抗菌活性的研究[J].2011,34 (11).
[11]Lee K,Lee Y,Lee H,etc.A novel insertion sequence, ISAba10, inserted into ISAba1 adjacent to the bla(OXA-23) gene and disrupting the outer membrane protein gene carO in Acinetobacter baumannii.[J].2011,55(1).
[12]Vila J,Marti S,Sanchez-Cespedes J.Porins, efflux pumps and multidrug resistance in Acinetobacter baumannii.[J].2007,59(6).
[13]Seifert H,Peleg AY,Paterson DL.Acinetobacter baumannii: emergence of a successful pathogen.[J].2008,21(3).
[14]Drawz SM,Bonomo RA.Three decades of beta-lactamase inhibitors.[J].2010,23(1).
[15]Max Gehrlein,Hermann Leying,Wolfgang Cullmann,etc.Imipenem Resistance in<i>Acinetobacter baumanii</i>Is Due to Altered Penicillin-Binding Proteins[J].1991,37(6).
[16]Tjernberg I,de Vos P,Vaneechoutte M,etc.Identification of Acinetobacter genomic species by amplified ribosomal DNA restriction analysis.[J].1995,33(1).
[17]Nowak, A.,Kur, J..Genomic species typing of acinetobacters by polymerase chain reaction amplification of the recA gene[J].1995,130(2).
[18]Heritier C,Poirel L,Nordmann P.Cephalosporinase over-expression resulting from insertion of ISAba1 in Acinetobacter baumannii.[J].2006,12(2).
[19]Federico, Perez,Andrea M, Hujer,Kristine M, Hujer,etc.Global challenge of multidrug-resistant Acinetobacter baumannii.[J].2007,51(10).
[20]Bonnin RA,Nordmann P,Gatermann SG,etc.NDM-2 carbapenemase in Acinetobacter baumannii from Egypt.[J].2011,66(6).
[21]Lee K,Yong D,Giske CG,etc.Characterization of a new metallo-beta-lactamase gene, bla(NDM-1), and a novel erythromycin esterase gene carried on a unique genetic structure in Klebsiella pneumoniae sequence type 14 from India.[J].2009,53(12).
[22]Drugeon H,Poirel L,Corvec S,etc.Genetics and expression of the carbapenem-hydrolyzing oxacillinase gene blaOXA-23 in Acinetobacter baumannii.[J].2007,51(4).
[23]Potoski BA,Harrison LH,Muto CA,etc.Genetic basis of multidrug resistance in Acinetobacter baumannii clinical isolates at a tertiary medical center in Pennsylvania.[J].2008,52(11).
[24]Jacoby GA.AmpC beta-lactamases.[J].2009,22(1).
[25]Rajeswari MR,Vashist J,Kapil A,etc.Analysis of penicillin-binding proteins (PBPs) in carbapenem resistant Acinetobacter baumannii.[J].2011,133(3).